Meclizine Hydrochloride Tablets USP recall: Labeling Error
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Why was Meclizine Hydrochloride Tablets USP recalled?
Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 22P0036, Exp 12/2024
- Product
- Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
- Recalling firm
- Jubilant Cadista Pharmaceuticals, Inc.
- Quantity
- 12,174 bottles
- Distribution
- Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.
- Recall date
- April 6, 2022
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)